Studies showed that FTO reduced the level of m6A on ASB2 and RARA mRNA transcripts, regulated the expression of targets, including ASB2 and RARA, inhibited the differentiation of AML cells induced by all-trans-retinoic acid (ATRA), and promoted the progression of AML [18]. This evidence concerns the gene FTO and acute myeloid leukemia.